MD Healthcare
MD Healthcare develops microbiome-based precision medicine for diagnostics and therapeutics. Their core technology uses microbial extracellular vesicles as biomarkers and postbiotics. They perform metagenomic analysis on tens of thousands of clinical samples and are building drug pipelines and AI-driven non-invasive diagnostics. The company targets immuno-oncology, respiratory, GI, skin, and CNS indications, with pre-clinical drug programs. Based in Seoul, MD Healthcare offers diagnostic tools and therapeutics through a biotechnology platform.
MD Healthcare
MD Healthcare develops microbiome-based precision medicine for diagnostics and therapeutics. Their core technology uses microbial extracellular vesicles as biomarkers and postbiotics. They perform metagenomic analysis on tens of thousands of clinical samples and are building drug pipelines and AI-driven non-invasive diagnostics. The company targets immuno-oncology, respiratory, GI, skin, and CNS indications, with pre-clinical drug programs. Based in Seoul, MD Healthcare offers diagnostic tools and therapeutics through a biotechnology platform.